Vista Pharmaceuticals Limited

₹6.74As of Sun 8 Nov 2026, 12:00 UTC
BSE:524711Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (9.59%)
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) 0.04
PE TTM —
TSR TTM (31.36%)
Mkt cap ₹414.9M
ROIC (9.22%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹6.65
(1.31%)
(83.19%)
Hold 2|9|11|10|0
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.08
0.08
0.08
0.09
(6.97%)
(5.11%)
4.82%
10.31%
Revenue₹M
40.68
42.09
42.12
43.38
2.27%
4.59%
1.02%
6.56%
Peers (US$4.188M)
Cap (US$)
PE
4.146M
4.302x
Capital
TTM
5Y
10Y
Leveragex
1.335
(0.083)
(0.084)
EBIT/Intx
1.481
0.202
0.142
Own earn%
424.62
199.25
201.55
Sh yield%
48.57
41.45
40.64
Owners
Insiders/Inst%
6.32
84.22
Short interest%
1.56
SBC / revenue%
4.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
4–9
$1 testx
−0.1
Incr. ROIC%
10